AMTM
Amentum Holdings, Inc.
AMTM's outlook is improving, though it still trails on the overall score.
VRT
Vertiv Holdings Co
VRT has the edge over AMTM overall, supported by stronger fundamentals and stronger valuation.
AMTM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Under pressure |
AMTM's profitability and cash flow are currently healthy, and its revenue is stable, but its balance sheet is under pressure.
VRT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
VRT's revenue, profitability, cash flow and balance sheet are all currently strong.
AMTM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 8.6x | $22.15 | — |
| Cheap | 26x | $21.30 | -3.8% |
| Current | 27x | $22.15 | — |
| Fair | 39x | $32.14 | +45% |
| Expensive | 108x | $89.29 | +303% |
Historical ranges are pointers, not guarantees.
AMTM has the edge over VRT in the historical PE scenario, which offers more potential upside but is not a forecast.
VRT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 23x | $210 | — |
| Current | 39x | $210 | — |
| Cheap | 58x | $308 | +47% |
| Fair | 72x | $383 | +83% |
| Expensive | 88x | $472 | +125% |
Historical ranges are pointers, not guarantees.
VRT's PE is in its cheap range at 39x. If earnings grow as analysts expect, today's price would be 23x next year's earnings.
AMTM Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect AMTM's earnings to grow and its profitability to improve, with its revenue holding steady.
VRT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
VRT has the edge over AMTM on the outlook, with more favorable revenue expectations.
AMTM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.58 | +211% |
| Q2 2026 | $0.83 | +$3.68 |
| Q1 2026 | $0.60 | +$3.66 |
| Q4 2025 | $0.40 | +$2.76 |
| Q3 2025 | $0.27 | +$1.96 |
| Q2 2025 | -$2.85 | -271% |
| Q1 2025 | -$3.06 | -280% |
| Q4 2024 | -$2.36 | -298% |
| Q3 2024 | -$1.69 | -349% |
AMTM has returned to profit: it earned $0.83 per share over the past year, after losing money the year before.
VRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.14 | +71% |
| Q3 2026 | $5.35 | +102% |
| Q2 2026 | $4.42 | +111% |
| Q1 2026 | $3.98 | +131% |
| Q4 2025 | $3.41 | +166% |
| Q3 2025 | $2.65 | +75% |
| Q2 2025 | $2.09 | +62% |
| Q1 2025 | $1.72 | +64% |
| Q4 2024 | $1.28 | +7.6% |
VRT has the edge over AMTM on earnings, with more consistent year-over-year improvement.
AMTM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $3.5B | -2% |
| Q1 2026 | $3.5B | -0.4% |
| Q4 2025 | $3.2B | -5.2% |
| Q3 2025 | $3.9B | -7.5% |
| Q2 2025 | $3.6B | +66% |
| Q1 2025 | $3.5B | +145% |
| Q4 2024 | $3.4B | +151% |
| Q3 2024 | $4.2B | +189% |
AMTM's revenue fell from its 2024 peak and has held roughly level since: $3.5B last quarter, down 2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 4.9% | +2 points |
| Q1 2026 | 4.3% | +1.2 points |
| Q4 2025 | 4.3% | +0.4 points |
| Q3 2025 | 3.4% | +2.8 points |
| Q2 2025 | 2.9% | -1.3 points |
| Q1 2025 | 3.1% | -3.2 points |
| Q4 2024 | 3.9% | -2.6 points |
| Q3 2024 | 0.6% | -6 points |
AMTM's operating margin was 4.9% last quarter, up 2 points from the same quarter a year ago.
VRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.3B | +61% |
| Q2 2026 | $3.3B | +24% |
| Q1 2026 | $2.6B | +30% |
| Q4 2025 | $2.9B | +23% |
| Q3 2025 | $2.7B | +29% |
| Q2 2025 | $2.6B | +35% |
| Q1 2025 | $2B | +24% |
| Q4 2024 | $2.3B | +26% |
VRT's revenue has grown year over year every quarter since late 2020: $4.3B last quarter, up 61% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +3.5 points |
| Q2 2026 | 19% | +2.7 points |
| Q1 2026 | 17% | +2.3 points |
| Q4 2025 | 20% | +0.7 points |
| Q3 2025 | 19% | +1.4 points |
| Q2 2025 | 17% | -0.4 points |
| Q1 2025 | 14% | +1.9 points |
| Q4 2024 | 19% | +4.2 points |
VRT has the edge over AMTM on profitability, with a higher operating margin.
AMTM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $135M | +35% |
| Q1 2026 | $220M | +315% |
| Q4 2025 | -$142M | -239% |
| Q3 2025 | $261M | +$378.2M |
| Q2 2025 | $100M | -58% |
| Q1 2025 | $53M | +2550% |
| Q4 2024 | $102M | +$187M |
| Q3 2024 | -$117.2M | -218% |
AMTM generated $474M in free cash flow over the past year, about three times what it generated the year before.
VRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $654.9M | +41% |
| Q2 2026 | $926.5M | +233% |
| Q1 2026 | $654.2M | +145% |
| Q4 2025 | $885.6M | +143% |
| Q3 2025 | $463.5M | +36% |
| Q2 2025 | $277.9M | -19% |
| Q1 2025 | $266.8M | +162% |
| Q4 2024 | $364.5M | +18% |
VRT has the edge over AMTM on cash flow, with more consistent year-over-year improvement.
AMTM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +0.8% | +2M shares |
| 3 years | +0.7% | +1.7M shares |
AMTM has 245M diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
VRT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -64.9K shares |
| 1 year | +0.4% | +1.8M shares |
| 3 years | +1.1% | +4.4M shares |
| 5 years | +10% | +36M shares |
| Available history | +63% | +152M shares |
VRT has the edge over AMTM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | $599.9M |
AMTM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 3.3x | Elevated |
| Q1 2026 | 3.5x | Elevated |
| Q4 2025 | 3.8x | Elevated |
| Q3 2025 | 3.5x | Elevated |
| Q2 2025 | 4.4x | High |
| Q1 2025 | 5.4x | High |
| Q4 2024 | 6.6x | High |
| Q3 2024 | 9.4x | High |
AMTM's net debt is about 3.3 years of its operating earnings (EBITDA), down from 4.4 years a year ago.
VRT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 1.0x | Healthy |
VRT has the edge over AMTM on leverage, with a lower net debt burden relative to earnings.
AMTM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.2 | Neutral |
| Stochastic | 54.9 | Neutral |
AMTM's weekly RSI is 51 (neutral) and its Stochastic is 55 (neutral).
VRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 26.4 | Neutral |
VRT's weekly RSI is 43 (neutral) and its Stochastic is 26 (neutral).
AMTM PE vs Industrials Sector
| Metric | AMTM | Sector median | Relative |
|---|---|---|---|
| PE | 27x | 24x | 11% above |
| PE % | 26 | 32 | 6 pts below |
AMTM has the edge over VRT on valuation relative to its sector.
VRT PE vs Industrials Sector
| Metric | VRT | Sector median | Relative |
|---|---|---|---|
| PE | 39x | 24x | 63% above |
| PE % | 3 | 58 | 55 pts below |
VRT is trading at 39x earnings, a 63% premium to the Industrials sector's median of 24x.
AMTM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $20.4 | 8.6% above |
| 20 week MA | $20.9 | 6% above |
| 50 week MA | $25.2 | 12% below |
| 100 week MA | $23.7 | 6.5% below |
AMTM has stronger trend alignment. AMTM is above 2 of 4 weekly averages versus VRT above 2 of 5.
VRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $221.8 | 5.5% below |
| 20 week MA | $254.4 | 18% below |
| 50 week MA | $253.9 | 17% below |
| 100 week MA | $189.1 | 11% above |
| 200 week MA | $123.5 | 70% above |
VRT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 70% above its 200-week average.
AMTM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $25.7 | $20.5 | -20% |
| 2025 | $20.5 | $29.7 | +45% |
| 2026 YTD | $29.7 | $22.2 | -25% |
AMTM has finished lower in one of the last two years. It's down 25% so far in 2026.
VRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.9 | $18.9 | +73% |
| 2021 | $18.9 | $24.9 | +31% |
| 2022 | $24.9 | $12.8 | -48% |
| 2023 | $12.8 | $48.0 | +275% |
| 2024 | $48.0 | $115.1 | +140% |
| 2025 | $115.1 | $167.6 | +46% |
| 2026 YTD | $167.6 | $209.6 | +25% |
VRT has the edge over AMTM on returns for 2026, with the stronger performance.